Clinical trial

Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity

NCT04800159

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention THC Cannabis Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CBD Cannabis Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-02-19

PhasePHASE2

Conditions

HIVunresolved

Cannabis Useunresolved

Interventions

THC CannabisDRUG

CBD CannabisDRUG

PlaceboDRUG

Sponsors & collaborators

University of California, San Diegolead sponsor

Center for Medicinal Cannabis Researchcollaborator

Mapped research locations

San DiegoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04800159 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.